Q3 2025 Globus Medical Inc Earnings Call Transcript
Key Points
- Globus Medical Inc (GMED) reported a strong Q3 performance with sales of $769 million, a 22.9% increase over the prior year.
- The company achieved a record free cash flow of $213.9 million for the third quarter.
- The US spine business led growth with a 9.6% increase, marking 32 consecutive weeks of growth.
- The recently acquired Nevro business contributed $99.3 million in revenue and achieved a positive adjusted EBITDA margin of 16.2%.
- Globus Medical Inc (GMED) revised its full-year financial guidance upward, reflecting confidence in continued market penetration and earnings expansion.
- Enabling technologies revenue declined by 27% compared to the prior year quarter, primarily due to lower sales of EGPS systems.
- The company faced challenges with precise manufacturing in its trauma business, although these are reportedly now behind them.
- There was a decline in enabling technology sales, with a $10.3 million decrease reported.
- The international spine business was impacted by supply chain prioritization for the US, affecting international supply.
- SG&A expenses increased to $313.6 million, or 40.8% of sales, due to one-time net charges for estimated litigation.
Welcome to Globus Medical's 3rd quarter, 2025 earnings call.
At this time, all lines
Will be on mute, and a Q&A session will be held after the prepared remarks.
To ask a question during the session, you will need to press star 11 on your telephone.
You will then hear an automated message advising your hand is right to withdraw your question, please 11 again.
Please be advised that today's conference is being recorded.
I will now turn the call over to Brian Kearns, senior vpof Business Development and investor relations.
Mr.
Kearns, please go ahead.
Thank you, Stephanie, and thank you everyone for being with us today.
Joining today's call from Globus Medical will be Keith File, President and CEO, and Kyle Klein, Chief Financial Officer.
This review is being made available via Webcast, accessible through the investor relations section of the Globus Medical website at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
